Dynamic nuclear polarisation of 1H in Gd-doped In(OH)3

Dynamic nuclear polarisation (DNP) of solids doped with high-spin metal ions, such as Gd3+, is a useful strategy to enhance the nuclear magnetic resonance (NMR) sensitivity for these samples. Spin diffusion can relay polarisation throughout a sample, which is most effective for dense 1H networks, while the efficiency of DNP using Gd3+ depends on the symmetry of the metal site. Here, we investigate cubic In(OH)3 as a high-symmetry, proton-containing material for endogenous Gd DNP. A 1H enhancement of up to 9 is demonstrated and harnessed to measure the 17O spectrum at natural abundance. The enhancement is interpreted in terms of clustering of the Gd3+ dopants and the local reduction in symmetry of the metal site induced by proton disorder, as demonstrated by quadrupolar 115In NMR. This is the first example of 1H DNP using Gd3+ dopants in an inorganic solid.

Unique features of brain metastases-targeted AGuIX nanoparticles vs their constituents: A focus on glutamate-/GABA-ergic neurotransmission in cortex nerve terminals

Gadolinium-based radiosensitizing AGuIX nanoparticles (AGuIX) currently tested two phase 2 clinical trials in association with radiotherapy for the treatment of brain metastases. Here, excitatory/inhibitory neurotransmission was assessed in rat cortex nerve terminals in the presence of AGuIX and their constituents (DOTAGA and DOTAGA/Gd³⁺) at concentrations used for medical treatment, and those 5-24 times higher. The ambient level, transporter-mediated, tonic and exocytotic release of L-[¹⁴C]glutamate and [³H]GABA, the membrane potential of nerve terminals were not changed in the presence of AGuIX at concentrations used for medical treatment ([Gd³⁺] = 0.25 mM, corresponding to 0.25 g.L^-1), and DOTAGA (0.25 mM) and DOTAGA/Gd³⁺ (0.25 mM/0.01 mM). Difference between AGuIX and the precursors was uncovered, when their concentrations were increased. AGuIX (1.25-6 mM) did not change any transport characteristics of L-[¹⁴C]glutamate and [³H]GABA, whereas, DOTAGA (1.25-6 mM) affected the membrane potential, ambient level, and exocytotic release of L-[¹⁴C]glutamate and [³H]GABA. Gd³⁺ did not mask, but even enhanced above effects of DOTAGA. Therefore, AGuIX did not influence glutamate- and GABA-ergic neurotransmission at the presynaptic site. In contrast, DOTAGA and mixture DOTAGA/Gd³⁺ significantly affected synaptic neurotransmission at high concentrations. AGuIX own structure that overcomes neurotoxic features of their constituents.